CLINICAL_TRIALS
trial_result
· 2015-07-01
Clinical Trial Update: RDEA3170 Monotherapy in Subjects With Gout [Phase 2]
Summary
This update reports the completion of a Phase 2 monotherapy trial of RDEA3170 in subjects with gout.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ardea Biosciences, Inc. | Conditions: Gout | Phase 2 | Status: COMPLETED